Showing results (1831-1840 of 2,371) with videos related to

Sort By:
Pageof 238
Nature Communications|June 22, 2023
Occurrence and backtracking of microplastic mass loads including tire wear particles in northern Atlantic airIsabel Goßmann, Dorte Herzke, Andreas Held, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2026
Chronic hypoxia protects the mouse heart from oxidative stress via HIF-1α-mitochondria crosstalkBarbora Opletalova, Lukas Alan, Miroslav Ferko, et al.
Gene Therapy|May 31, 2003
Titer determination of Ad5 in blood: a cautionary noteG Cichon, S Boeckh-Herwig, D Kuemin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft modelL A Hammond, S G Hilsenbeck, S G Eckhardt, et al.
Plos One|April 22, 2020
Novel approach to visualize the inter-dependencies between maternal sensitization, breast milk immune components and human milk oligosaccharides in the LIFE Child cohortLoris Michel, Maya Shevlyakova, Ellen Ní Cléirigh, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
Pediatrics|August 8, 2012
Maternal HIV infection and vertical transmission of pathogenic bacteriaClare L Cutland, Stephanie J Schrag, Elizabeth R Zell, et al.
Blood|March 3, 2005
Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulationFalk Martin, Tobias Linden, Dörthe M Katschinski, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trialM A Graham, S Senan, H Robin, et al.
European Heart Journal|January 17, 2023
Cognitive-behavioural therapy reduces psychological distress in younger patients with cardiac disease: a randomized trialAnnette Holdgaard, Christine Eckhardt-Hansen, Christina Funch Lassen, et al.
Pageof 238